Skip to content
MedsAcross

Medicine

Sterile Cord Blood Collection Unit (msc123d) 114.5 g/0.89 g/0.92 g/87.9 g per 35 mL injection

Available on requestPrescription onlyUS FDA

Sterile Cord Blood Collection Unit (msc123d) 114.5 g/0.89 g/0.92 g/87.9 g per 35 mL injection is a prescription medicine containing Citric acid, Dextrose, Sodium citrate and Sodium phosphate, monobasic, for intravenous use, marketed by Maco Productions, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Storage as on the product label

Key facts

Active ingredient (INN)
Citric acid, Dextrose, Sodium citrate and Sodium phosphate, monobasic,
Brand
Sterile Cord Blood Collection Unit (msc123d)
Strength
114.5 g/0.89 g/0.92 g/87.9 g per 35 mL
Dosage form
Injection
Route
Intravenous
Packs
1 kit of 35 mL
Marketing authorisation holder
Maco Productions
Manufacturer
Maco Productions
Origin register
US FDA, United States
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 October 2020
Identifiers
DailyMed set ID e3b456ec-4578-485f-a696-8a343505f30bNDC 14498-005Application BN125552

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 kit in 1 kit / 35 mL in 1 kit14498-005-01Maco Productions2 October 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Citric acid, Dextrose, Sodium citrate and Sodium phosphate, monobasic,

Clinical summary

Citric acid, Dextrose, Sodium citrate and Sodium phosphate, monobasic, is a fixed-dose combination of an anti-coagulant and a calculi dissolution agent. It is available as injection for intravenous use. MedsAcross supplies Citric acid, Dextrose, Sodium citrate and Sodium phosphate, monobasic, for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Citric acid, Dextrose, Sodium citrate and Sodium phosphate, monobasic,

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sterile Cord Blood Collection Unit (msc123d) 114.5 g/0.89 g/0.92 g/87.9 g per 35 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.